Hudaco Industries Limited (JSE:HDC)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 19,002
-301 (-1.56%)
Jul 31, 2025, 12:51 PM SAST
Marinus Pharmaceuticals Cash Flow Statement
Financials in millions ZAR. Fiscal year is December - November.
Millions ZAR. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2016 - 2020 |
Net Income | 549.74 | 505.74 | 610.81 | 596.27 | 498.72 | 35.56 | Upgrade |
Depreciation & Amortization | 194.37 | 188.37 | 168.89 | 169.4 | 164.58 | 183.57 | Upgrade |
Other Amortization | 5.46 | 5.46 | 7.38 | 5.03 | - | - | Upgrade |
Loss (Gain) From Sale of Assets | -2.21 | -0.21 | -1.66 | -0.54 | -3.92 | 0.58 | Upgrade |
Asset Writedown & Restructuring Costs | -4.6 | -4.6 | -0.69 | 0.08 | 2.76 | - | Upgrade |
Stock-Based Compensation | 41.2 | 45.2 | 48.87 | 55.76 | 36.08 | 31.19 | Upgrade |
Other Operating Activities | 226.64 | 296.64 | 200.47 | 178.83 | 107.48 | 396.96 | Upgrade |
Change in Accounts Receivable | 184.06 | 184.06 | -76.73 | -83.39 | -52.09 | 59.56 | Upgrade |
Change in Inventory | 242.73 | 242.73 | -285.41 | -292.36 | -405.61 | 129.68 | Upgrade |
Change in Accounts Payable | -105.42 | -105.42 | -50.29 | 34.86 | 335.66 | -17.97 | Upgrade |
Change in Other Net Operating Assets | -159.56 | -23.56 | 20.15 | -14.54 | 5.75 | 11.13 | Upgrade |
Operating Cash Flow | 1,172 | 1,334 | 641.78 | 649.41 | 689.4 | 830.26 | Upgrade |
Operating Cash Flow Growth | 15.99% | 107.92% | -1.17% | -5.80% | -16.96% | 26.39% | Upgrade |
Capital Expenditures | -72.57 | -78.57 | -105.23 | -78.07 | -69.47 | -37.37 | Upgrade |
Sale of Property, Plant & Equipment | 7.49 | 7.49 | 9.18 | 7.69 | 8.39 | 5.72 | Upgrade |
Cash Acquisitions | -319.02 | -112.02 | -171.04 | -80.94 | 9.35 | -6.07 | Upgrade |
Sale (Purchase) of Intangibles | -6.41 | -4.41 | -7.74 | -5.82 | -6.42 | -7.41 | Upgrade |
Investment in Securities | - | - | - | 0.15 | 0.04 | - | Upgrade |
Investing Cash Flow | -390.51 | -187.51 | -274.83 | -157 | -58.12 | -45.13 | Upgrade |
Long-Term Debt Issued | - | - | 400 | 400 | 40 | 147.1 | Upgrade |
Long-Term Debt Repaid | - | -512.3 | -105.8 | -394.41 | -283.15 | -376.65 | Upgrade |
Net Debt Issued (Repaid) | -265.3 | -512.3 | 294.2 | 5.59 | -243.15 | -229.55 | Upgrade |
Repurchase of Common Stock | - | - | -111.7 | -133.2 | -69.03 | -81.82 | Upgrade |
Common Dividends Paid | -289.98 | -290.98 | -269.69 | -244 | -198.07 | -129.75 | Upgrade |
Other Financing Activities | -255.73 | -311.73 | -271.31 | -154.63 | -99.12 | -115.72 | Upgrade |
Financing Cash Flow | -811.01 | -1,115 | -358.5 | -526.24 | -609.37 | -556.84 | Upgrade |
Foreign Exchange Rate Adjustments | -2.15 | -8.15 | 0.17 | 1.28 | 3.06 | -1.88 | Upgrade |
Net Cash Flow | -31.28 | 23.72 | 8.62 | -32.55 | 24.98 | 226.42 | Upgrade |
Free Cash Flow | 1,100 | 1,256 | 536.55 | 571.34 | 619.93 | 792.89 | Upgrade |
Free Cash Flow Growth | 17.43% | 134.05% | -6.09% | -7.84% | -21.81% | 35.51% | Upgrade |
Free Cash Flow Margin | 13.28% | 14.99% | 6.03% | 7.01% | 8.54% | 12.68% | Upgrade |
Free Cash Flow Per Share | 37.80 | 43.31 | 18.16 | 18.47 | 20.01 | 25.15 | Upgrade |
Cash Interest Paid | 16.29 | 38.29 | 37.8 | 86.64 | 68.01 | 103.47 | Upgrade |
Cash Income Tax Paid | 235.81 | 204.81 | 259.87 | 244.02 | 219.73 | 112.62 | Upgrade |
Levered Free Cash Flow | 658.98 | 970.39 | 155.15 | 309.81 | 498.87 | 608.27 | Upgrade |
Unlevered Free Cash Flow | 740.83 | 1,066 | 248.97 | 363.96 | 541.37 | 672.94 | Upgrade |
Change in Net Working Capital | 51 | -283.29 | 532.02 | 402.25 | 99.53 | -183.76 | Upgrade |
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.